DJIA 16,790.19 13.76 0.08%
NASDAQ 4,748.36 -32.90 -0.69%
S&P 500 1,979.92 -7.13 -0.36%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

38.59 -1.70 (-4.22%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $38.59 -4.22%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.88
Previous Close $40.29
Daily Range $37.26 - $41.88
52-Week Range $30.05 - $52.33
Market Cap $4.8B
P/E Ratio -45.27
Dividend (Yield) $0.00 (0.0%)
Volume 1,461,477
Average Daily Volume 1,288,991
Current FY EPS -$0.95




Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary

Why Biotech Took a Beating Today

What goes up must come down.

3 Biotech Stocks Loved by Portfolio Managers Now

Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech

Water-Logged And Getting Wetter Stock Of The Day: Seattle Genetics (SGEN)

Interesting SGEN Put And Call Options For November 20th

3 Mid-Cap Biotechs We're Excited About

Our healthcare contributors think you should add these mid-cap biotechs to your watch list.

American Eagle Outfitters, Sears And Others That Insiders Have Been Buying

Insiders Are Buying Barnes & Noble

Insiders Are Buying Barnes & Noble

Global Imbalances and the Chinese Economy - John Mauldin

See More SGEN News...

SGEN's Top Competitors

SGEN $38.59 (-4.22%)
Current stock: SGEN
AMGN $141.22 (-1.79%)
Current stock: AMGN
GILD $97.54 (-1.73%)
Current stock: GILD
BIIB $275.99 (-3.69%)
Current stock: BIIB